A randomized clinical trial for comparing the efficacy of desensitizing toothpastes on the relief of dentin hypersensitivity

Sci Rep. 2023 Mar 31;13(1):5271. doi: 10.1038/s41598-023-31616-6.

Abstract

The 4-week double-blind clinical trial to manage dentin hypersensitivity (DH) using different desensitizing toothpastes was conducted. 53 participants with DH were enrolled in this trial. The participants were randomized into 3 groups: Group N; no active ingredient-containing toothpaste (Pleasia fluoride-free), Group SC; a toothpaste containing strontium chloride (Sensodyne Original), and Group TP; a toothpaste containing tricalcium phosphate (Vussen S). They were instructed to brush their teeth manually for 3 min, 3 times per day for 4 weeks with the allocated toothpastes, and were assessed at baseline (0), 2, and 4 weeks, respectively. Schiff sensitivity score was recorded to 3 different stimuli (air-blast, cold, and acid) at each assessment. Overall DH was also assessed using a visual analog scale (VAS). The longer participants used the toothpastes, the greater reduction in DH in all groups to the three stimuli. Group TP demonstrated significant reduction of DH compared to group N for air-blast and cold stimuli. Group TP showed significantly lower VAS than group N and SC. Tricalcium phosphate containing toothpaste used in this trial was most useful to reduce DH. It can be one of the treatment options that alleviate DH.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arginine / therapeutic use
  • Dentin Desensitizing Agents* / therapeutic use
  • Dentin Sensitivity* / drug therapy
  • Double-Blind Method
  • Fluorides / therapeutic use
  • Humans
  • Sodium Fluoride / therapeutic use
  • Toothpastes / therapeutic use
  • Treatment Outcome

Substances

  • Toothpastes
  • tricalcium phosphate
  • Sodium Fluoride
  • Dentin Desensitizing Agents
  • Arginine
  • Fluorides